From: 18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
PET parameter
Mean
Median
Range
IQR
Tumoral SUV max
20.3
16.6
[2.2, 78.21]
12.12–23.74
SUV mean
6.9
6.1
[1.7, 18.92]
5.33–7.54
MTV (mL)
197.6
60.2
[0.03, 2694]
13.47–212.74
SLR
0.9
[0.669, 1.364]
0.81–0.97